Investors in It

Mérieux Equity Partners is one of the most recognized and active European Investment firms in the Healthcare sector. We support the development and growth of high-potential companies from business launch to large scale deployment through capital investment and tailor-made support based on our strong sector expertise and international network. We are an agile investor with a flexible approach in terms of minority or majority stakes. Our main focus is partnering with and investing alongside management teams.

France Pre-Seed / Seed, Series A/B, Series C & Beyond
Above €3M

We help entrepreneurs succeed. It has been our mission from day one. We challenge existing paradigms of how things are done in the normal VC world. We invest ourselves and money in early-stage companies.We partner with the most talented entrepreneurs – bringing to the table industry know-how, relentless dedication and money to move startups fast forward.

Denmark Pre-Seed / Seed, Series A/B
€100k-€1.5M

At Korelya Capital, we are firm believers that the next generation of technology leaders will emerge from Europe. We see immense potential in digital investment opportunities to drive growth and foster social progress across the continent. The ongoing digital revolution is already reshaping every aspect of our lives—from how we work and access information to how we produce and consume goods and services. It is set to liberate us from repetitive tasks, transform urban living, simplify travel, and mitigate risks. Looking ahead, we anticipate that Europe will produce unprecedented success stories in the digital economy over the next decade. The European tech ecosystem is maturing rapidly, bolstered by advancements in mindset, access to capital, technological expertise, and talent. Key technologies such as Artificial Intelligence, IoT, and Big Data will play pivotal roles in the next phase of digital transformation, succeeding the era of platformization that has reshaped our economies and societies.

France Pre-Seed / Seed, Series A/B, Series C & Beyond
Above €3M

Newfund

VC Firm

Founded in 2008 by and for founders, Newfund Capital is an early-stage VC firm actively investing in France and the USA. We foster a strong entrepreneurial culture and support the ambitions of our portfolio companies through various initiatives. With $300 million in assets under management (AUM), primarily subscribed by entrepreneurs and family offices, Newfund focuses on a people-driven investment strategy. We prioritize entrepreneurs who are deeply committed to realizing their vision, valuing their individuality and strengths. Our initial investments range from $250k to $2M, with smaller commitments starting at $100k in the Nouvelle Aquitaine region through our NAEH fund. Beyond financial support, we offer access to our operating team and a robust cross-border ecosystem to help founders achieve product-market fit and accelerate growth. At Newfund, we emphasize founders with significant skin in the game, reflecting our own commitment as a major limited partner (LP) in each fund. Our interests are fully aligned with those of our portfolio companies, ensuring a partnership without conflicts of interest.

France Pre-Seed / Seed, Series A/B
Above €3M

Aster

VC Firm

Aster is a seasoned venture capital firm specializing in Climate Tech investments, with a strong focus on industries that are traditionally challenging to decarbonize. With over two decades of experience, Aster targets sectors including energy, logistics, mobility, manufacturing, construction, chemicals, agriculture, and beyond. Their investment strategy likely emphasizes supporting technologies and innovations that promote sustainability and reduce carbon footprints within these sectors. For further details about Aster and their specific investment criteria, you can visit their official website at Aster.

France Pre-Seed / Seed, Series A/B, Series C & Beyond
€1.5M-€3M

HCVC

VC Firm

HCVC is a venture capital firm that focuses on supporting founders who are tackling significant challenges with innovative solutions. They specialize in investing in pre-seed and seed-stage companies that utilize breakthrough technologies to drive digital transformation, automation, and decarbonization initiatives globally. Their approach involves providing not only financial capital but also resources and collaborative support to help these early-stage companies grow and succeed in their missions. This includes leveraging advanced technologies to address pressing issues such as sustainability and efficiency across various industries. For more detailed information about HCVC and their investment philosophy, you can visit their official website at HCVC.

France Pre-Seed / Seed, Series A/B, Series C & Beyond
Above €3M

Seventure Partners is a long-term equity investor dedicated to supporting innovative companies that generate positive impacts on humankind, society, sustainability, and the planet. With €950 million in net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe, investing since 1997 in high-growth potential businesses across two main areas: Life sciences and Digital technologies. Our life sciences investments span biotech, health & digital health, nutrition, foodtech, blue economy, aquaculture, animal & agriculture, sport & wellness, with a particular focus on microbiome-related innovations across Europe, Israel, Asia, and North America. In the digital technologies sector, we invest in fintech, retailtech, and more, primarily in Western Europe.

France Pre-Seed / Seed, Series A/B, Series C & Beyond
€100k-€1.5M

KAYA

VC Firm

KAYA is an early-stage VC fund with roots in CEE, investing in intrepid founders across Europe since 2010. KAYA VC predominantly invests at the seed stage, but there is a growing focus on pre-seed opportunities. They have co-created seven ventures so far and are always seeking new studio projects. Even if an idea is still in its early stages, it is not too early to engage with them. For Seed+, Series A/A+, and businesses with revenue ranging from 0 to €5 million, they are open to making an initial investment. Recognizing the uniqueness of each situation, their initial investment can range from €100,000 to €3 million. KAYA VC has the capacity to invest over €20 million per company over time, leveraging their flagship fund and LPs. They prioritize potential over ownership percentages, preferring to hold 5% of a future unicorn rather than none.

Czech Republic Pre-Seed / Seed, Series A/B
€100k-€1.5M

Breega

VC Firm

Breega empowers visionary and purpose-driven founders to translate ideas into meaningful impact. Since closing our first fund in 2015, we've grown to manage €600 million in assets under management (AUM) and support over 100 pioneering portfolio companies. Built by founders for founders, Breega is dedicated to offering startups the support and resources we wish we had when starting out. We've developed a unique investment approach called full stack funding, which encompasses capital, strategic connections, expertise, and unwavering support throughout the entrepreneurial journey. Operating across Europe and globally, we focus on investing in startups from pre-seed to Series B stages, nurturing their growth and success.

France Pre-Seed / Seed, Series A/B
€1.5M-€3M

ZAKA VC

VC Firm

ZAKA is here not only to help promising talents with financing, but also to actively support them during their entrepreneurial journey.ZAKA VC is a top family venture house investing in early-stage tech startups globally, with a focus on pre-seed and seed investments in Europe. VC family office focused on pre-seed and seed investments all across Europe. Operating from Prague and Bratislava.

Czech Republic Pre-Seed / Seed
€100k-€1.5M

Truffle Capital, founded in 2001, is an independent European venture capital firm specializing in disruptive technologies in IT (FinTech and InsurTech) and Life Sciences (BioTech and MedTech). Our goal is to support the creation and growth of innovative companies with the potential to become future market leaders. Chaired by Patrick Kron and founded by Philippe Pouletty and Bernard-Louis Roques, we have raised over $1.1 billion and have supported more than 75 companies in the digital technologies and life sciences sectors. In 2017, we successfully completed the first close of our Truffle Financial Innovation Fund, Truffle BioMedTech Fund, and a fund dedicated to the French Reserve Fund. By December 2019, we had raised nearly €400 million for our new Venture Capital funds: Truffle BioMedTech Fund and Truffle Financial Innovation Fund. Our commitment is to drive innovation and support the next generation of industry leaders.

France Pre-Seed / Seed, Series A/B
Above €3M

Frst

VC Firm

At First, we consider ourselves entrepreneurs who recognize and support the creation of legendary entrepreneurs. We have crafted an ideal partnership model designed specifically for these unique individuals. We provide a significant investment at Day One, sometimes even before the company is formally established. Our approach ensures that we are a responsive, reliable, and knowledgeable partner with aligned interests. We aim to build long-term relationships that extend over a decade, supporting the growth and success of our portfolio companies. To date, Frst has invested over €200 million in more than 50 companies, with our full portfolio available on frst.vc. If you're a visionary entrepreneur looking for a partner who understands your journey from inception to success, we invite you to explore how Frst can support your ambitions.

France Pre-Seed / Seed, Series A/B
€1.5M-€3M
Showing 1333-1344 of 1789 items